Can newer blood thinners beat aspirin for clot prevention in blood cancer patients?
NCT ID NCT05198960
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 trial is testing whether direct oral anticoagulants (DOACs) like apixaban or rivaroxaban are better than low-dose aspirin at preventing blood clots in people with JAK2V617F-positive myeloproliferative neoplasms (blood cancers). The study plans to enroll 1308 high-risk patients. The goal is to see if these newer blood thinners reduce the risk of dangerous clots without causing too much bleeding.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Apixaban or Rivaroxaban (blood thinners)
- What this could lead to
- If successful, this could offer a more effective way to prevent dangerous blood clots in people with certain blood cancers, potentially reducing strokes and heart attacks.
- What could go wrong
- This is a large phase 3 trial, but blood thinners carry a risk of serious bleeding. It is unclear if the benefits will outweigh this risk in this specific patient group.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL THROMBOCYTHEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CH Bretagne Atlantique Vannes
RECRUITINGVannes, 56017, France
-
CH Le Mans
NOT_YET_RECRUITINGLe Mans, 72000, France
-
CH Libourne
NOT_YET_RECRUITINGLibourne, 33500, France
-
CH Paul-Brousse (APHP)
NOT_YET_RECRUITINGVillejuif, 94800, France
-
CH d'Annecy
NOT_YET_RECRUITINGAnnecy, 74374, France
-
CH d'Argenteuil
NOT_YET_RECRUITINGArgenteuil, 95100, France
-
CH d'Avignon
RECRUITINGAvignon, 84000, France
-
CH de Béziers
NOT_YET_RECRUITINGBéziers, 34500, France
-
CH de Morlaix
RECRUITINGMorlaix, 29600, France
-
CH de Perpignan
NOT_YET_RECRUITINGPerpignan, 66000, France
-
CH de Périgueux
RECRUITINGPérigueux, 24019, France
-
CH de Rochefort
NOT_YET_RECRUITINGRochefort, 17300, France
-
CH de Roubaix
RECRUITINGRoubaix, 59100, France
-
CH de Versailles
NOT_YET_RECRUITINGVersailles, 78150, France
-
CH de la Côte Basque Bayonne
NOT_YET_RECRUITINGBayonne, 64100, France
-
CHD Vendée La Roche Sur Yon
RECRUITINGLa Roche-sur-Yon, 85925, France
-
CHIC de Quimper
RECRUITINGQuimper, 29107, France
-
CHR d'Orléans
RECRUITINGOrléans, 45100, France
-
CHU Bordeaux
RECRUITINGBordeaux, 33604, France
-
CHU Brest
RECRUITINGBrest, 29609, France
-
CHU Grenoble Alpes
RECRUITINGGrenoble, 38043, France
-
CHU La Réunion - Site Nord Félix GUYON
NOT_YET_RECRUITINGSaint-Denis, 97405, France
-
CHU La Réunion - Site Sud
NOT_YET_RECRUITINGSaint-Pierre, 97410, France
-
CHU Le Havre
NOT_YET_RECRUITINGLe Havre, 76083, France
-
CHU d'Angers
RECRUITINGAngers, 49933, France
-
CHU de Clermont-Ferrand
NOT_YET_RECRUITINGClermont-Ferrand, 63003, France
-
CHU de Limoges - Hôpital Dupuytren
RECRUITINGLimoges, France
-
CHU de Montpellier
NOT_YET_RECRUITINGMontpellier, 34295, France
-
CHU de Nancy
RECRUITINGNancy, 54511, France
-
CHU de Nantes - Hôtel-Dieu
NOT_YET_RECRUITINGNantes, 44093, France
-
CHU de Rennes
NOT_YET_RECRUITINGRennes, 35033, France
-
CHU de Tours
RECRUITINGTours, 37044, France
-
Centre Henri Becquerel de Rouen
RECRUITINGRouen, 76038, France
-
Centre Léon Bérard Lyon
NOT_YET_RECRUITINGLyon, 69000, France
-
Clinique Sainte Anne Strasbourg
NOT_YET_RECRUITINGStrasbourg, 92210, France
-
Hôpital Cochin (APHP)
NOT_YET_RECRUITINGParis, 75679, France
-
Hôpital Henri Mondor (APHP)
RECRUITINGCréteil, 94010, France
-
Hôpital Privé du Confluent Nantes
NOT_YET_RECRUITINGNantes, 44202, France
-
Hôpital St-Louis (APHP)
RECRUITINGParis, 75010, France
-
Hôpital privé Cesson-Sévigné
NOT_YET_RECRUITINGCesson-Sévigné, 35510, France
-
Institut de Cancérologie Lucien Neuwirth St-Priest-en-Jarez
RECRUITINGSaint-Priest-en-Jarez, 42271, France
-
Médipôle Hôpital Mutualiste Villeurbanne
RECRUITINGVilleurbanne, 69616, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a hormone mimic curb the need for bloodletting in a blood cancer?
- Can a Dual-Action pill tame bone marrow tumors?
- Can a new drug reduce bloodletting for polycythemia vera?
- A simple Note-Taking change could transform blood cancer care
- Can a new drug help when standard treatment fails for polycythemia vera?
- Can a biologic drug outperform standard therapy for a rare blood cancer?